<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903471</url>
  </required_header>
  <id_info>
    <org_study_id>SHCHE201901</org_study_id>
    <nct_id>NCT03903471</nct_id>
  </id_info>
  <brief_title>22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA</brief_title>
  <official_title>Comparion of 22G-ProCore and 22G-Standard Needle in Diagnosis of Lymphadenopathy Via EBUS-TBNA: A Prospective, Multicenter, Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jiayuan Sun</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Chest Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the performance of 22G-ProCore and 22G-Standard needle in
      diagnosis of mediastinal and hilar lymphadenopathy via EBUS-TBNA with the purpose to explore
      the optimal technique for obtaining diagnostic material.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EBUS-TBNA is an important minimally invasive tool for the diagnosis of mediastinal and hilar
      lymphadenopathy. The investigators will explore the performance of two kinds of needles and
      different methods to obtain tissues via EBUS-TBNA in the study. The study is designed as a
      prospective, multicenter, randomized controlled trial, 600 patients will be expected to
      enroll in the study and randomly assigned to two groups, the 22G-ProCore group and the
      22G-Standard group. The primary aim is to compare the diagnostic yields of the two types of
      needles. The secondary endpoint is to assess the quality of histologic specimen. Meanwhile,
      stylet slow-pull or negative suction techniques and different agitations (10, 20, 30 times)
      that each pass includes will be evaluated in the study as well.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield of 22G-ProCore needle</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Diagnostic yield is defined as percentage of specimens in which diagnostic material is obtained.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnostic yield of 22G-Standard needle</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Diagnostic yield is defined as percentage of specimens in which diagnostic material is obtained.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The quality of histologic specimen used by 22G-ProCore needle</measure>
    <time_frame>up to 6 months</time_frame>
    <description>The number and ratio of cellularity, blood contamination, and core-tissue acquisition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The quality of histologic specimen used by 22G-Standard needle</measure>
    <time_frame>up to 6 months</time_frame>
    <description>The number and ratio of cellularity, blood contamination, and core-tissue acquisition.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Diagnostic yield of aspiration techniques</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Conventional EBUS-TBNA procedures involve use of 10mL negative suction aspiration techniques. A new aspiration method, the stylet slow-pull technique, involves slow withdrawal of the needle stylet to create minimum negative pressure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Diagnostic yield of different agitations</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Agitation means needle moving 10 or 20 or 30 times back and forth in lymph nodes per pass.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Lymph Node Disease</condition>
  <arm_group>
    <arm_group_label>22G-ProCore Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group with 22G-ProCore needle is expected to enroll 300 patients. The 22G-ProCore needle has a 1.5mm long groove 2.5mm above the needle tip, which is expected to have the advantage of taking more biopsy tissues than the 22G-Standard needle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>22G-Standard Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group of 22G-Standard needle is expected to include 300 patients, and there is no groove above the needle tip compared with 22G-ProCore needle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>22G-ProCore Endobronchial Ultrasound Needle</intervention_name>
    <description>EchoTip Procore® Endobronchial HD Ultrasound Biopsy Needle, COOK</description>
    <arm_group_label>22G-ProCore Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>22G-Standard Endobronchial Ultrasound Needle</intervention_name>
    <description>EchoTip® Ultra Endobronchial High Definition Ultrasound Needle, COOK</description>
    <arm_group_label>22G-Standard Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Imaging examination indicates enlarged intrathoracic lymph nodes need pathological
             diagnosis (any lymph node has a short diameter &gt; 1 cm in CT or PET-CT SUV value &gt;
             2.5).

          2. Accessible mediastinal and hilar lymphadenopathy to EBUS-TBNA.

          3. Inform consent signed.

        Exclusion Criteria:

          1. Contraindications of EBUS-TBNA. Such as use of anticoagulant therapy or presence of a
             coagulopathy (platelet count &lt; 50000 or INR &gt; 1.5).

          2. Severe cardiopulmonary dysfunction and other indications that can't tolerate
             bronchoscopy.

          3. Life expectancy less than 6 months.

          4. Uncooperative patients.

          5. Patients representing vulnerable populations (prisoners, pregnant women, etc).

          6. Researchers consider it inappropriate to participate in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qi Wu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Cancer Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hao Xu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiayuan Sun, PhD</last_name>
    <phone>+86-021-22200000</phone>
    <phone_ext>1511</phone_ext>
    <email>jysun1976@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Chest Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiayuan Sun, PhD</last_name>
      <phone>+86-021-22200000</phone>
      <phone_ext>1511</phone_ext>
      <email>jysun1976@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Stamatis G. Staging of lung cancer: the role of noninvasive, minimally invasive and invasive techniques. Eur Respir J. 2015 Aug;46(2):521-31. doi: 10.1183/09031936.00126714. Epub 2015 May 14. Review.</citation>
    <PMID>25976686</PMID>
  </reference>
  <reference>
    <citation>Sun J, Zhang J, Zhao H, Shen J, Gu A, Han B. Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma: Experience of a single institution in China. Thorac Cancer. 2010 May;1(1):28-34. doi: 10.1111/j.1759-7714.2010.00010.x.</citation>
    <PMID>27755785</PMID>
  </reference>
  <reference>
    <citation>Sun J, Teng J, Yang H, Li Z, Zhang J, Zhao H, Garfield DH, Han B. Endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing intrathoracic tuberculosis. Ann Thorac Surg. 2013 Dec;96(6):2021-7. doi: 10.1016/j.athoracsur.2013.07.005. Epub 2013 Sep 12.</citation>
    <PMID>24035300</PMID>
  </reference>
  <reference>
    <citation>Sun J, Yang H, Teng J, Zhang J, Zhao H, Garfield DH, Han B. Determining factors in diagnosing pulmonary sarcoidosis by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Surg. 2015 Feb;99(2):441-5. doi: 10.1016/j.athoracsur.2014.09.029. Epub 2014 Dec 12. Erratum in: Ann Thorac Surg. 2015 Jun;99(6):2257.</citation>
    <PMID>25497069</PMID>
  </reference>
  <reference>
    <citation>Yang H, Wang S, Teng J, Han B, Sun J. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing non-specific inflammatory intrathorcacic lymphadenitis. Clin Respir J. 2018 Feb;12(2):691-698. doi: 10.1111/crj.12580. Epub 2016 Nov 23.</citation>
    <PMID>27882677</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 31, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Chest Hospital</investigator_affiliation>
    <investigator_full_name>Jiayuan Sun</investigator_full_name>
    <investigator_title>Director, Department of Respiratory Endoscopy and Interventional Pulmonology, Shanghai Chest Hospital</investigator_title>
  </responsible_party>
  <keyword>ProCore</keyword>
  <keyword>Mediastinal and Hilar Lymphadenopathy</keyword>
  <keyword>EBUS-TBNA</keyword>
  <keyword>Diagnostic Yield</keyword>
  <keyword>Quality of Specimen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphadenopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

